Dosage form: tablet
Drug class:Alkylating agents
Medically reviewed by Drugs.com. Last updated on Aug 1, 2020.
On This Page
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Drug Interactions
- Use In Specific Populations
- Overdosage
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- References
- How Supplied/Storage and Handling
- Patient Counseling Information
Indications and Usage for Cyclophosphamide
Malignant Diseases
Cyclophosphamide Tablets is indicated for the treatment of:
- •
- malignant lymphomas (Stages III and IV of the Ann Arbor staging system), Hodgkin’s disease, lymphocytic lymphoma (nodular or diffuse), mixed-cell type lymphoma, histiocytic lymphoma, Burkitt’s lymphoma
- •
- multiple myeloma
- •
- leukemias: chronic lymphocytic leukemia, chronic granulocytic leukemia (it is usually ineffective in acute blastic crisis), acute myelogenous and monocytic leukemia, acute lymphoblastic (stem-cell) leukemia (Cyclophosphamide given during remission is effective in prolonging its duration)
- •
- mycosis fungoides (advanced disease)
- •
- neuroblastoma (disseminated disease)
- •
- adenocarcinoma of the ovary
- •
- retinoblastoma
- • ...
